| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 3 securities · may seek to influence control | ||||||
|
Dermata Therapeutics, Inc.
13D/A
DRMA · 249845504
|
17.3% |
2/23/2026
Event 2/19/2026
|
||||
|
Dermata Therapeutics, Inc.
13D/A
DRMA · 249845405
|
13.3% |
4/7/2025
Event 3/27/2025
|
||||
| Proehl Gerald T | 13.3% | |||||
| Proehl Investment Ventures LLC | 13.3% | |||||
|
Dermata Therapeutics, Inc.
13D/A
DRMA · 249845108
|
7.8% |
4/3/2025
Event 3/27/2025
|
||||
| Proehl Gerald T | 7.8% | |||||
| Proehl Investment Ventures LLC | 7.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.